Dr. Elizabeth Dole, M.D

NPI: 1043342769
Total Payments
$779.72
2023 Payments
$54.00
Companies
4
Transactions
11

Payment Breakdown by Category

Food & Beverage$725.72 (93.1%)
Education$54.00 (6.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $725.72 10 93.1%
Education $54.00 1 6.9%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $413.31 7 $0 (2018)
E.R. Squibb & Sons, L.L.C. $293.63 2 $0 (2018)
Medtronic, Inc. $54.00 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $18.78 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $54.00 1 Medtronic, Inc. ($54.00)
2018 $181.30 3 E.R. Squibb & Sons, L.L.C. ($116.46)
2017 $544.42 7 Novartis Pharmaceuticals Corporation ($348.47)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/08/2023 Medtronic, Inc. FUSION (Device) Education In-kind items and services $54.00 General
Category: Image Guided Surgery Products
06/13/2018 Novartis Pharmaceuticals Corporation BINIMETINIB (Drug) Food and Beverage In-kind items and services $16.53 General
06/04/2018 Novartis Pharmaceuticals Corporation BINIMETINIB (Drug) Food and Beverage In-kind items and services $48.31 General
04/17/2018 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $116.46 General
Category: Oncology
11/07/2017 Otsuka America Pharmaceutical, Inc. BREATHTEK (Device) Food and Beverage In-kind items and services $18.78 General
Category: GASTROENTEROLOGY
07/10/2017 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $177.17 General
06/02/2017 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $114.78 General
Category: ONCOLOGY
05/05/2017 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $59.82 General
Category: ONCOLOGY
05/05/2017 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $11.58 General
Category: ONCOLOGY
01/30/2017 Novartis Pharmaceuticals Corporation BINIMETINIB (Drug) Food and Beverage In-kind items and services $96.00 General
01/09/2017 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $66.29 General
Category: ONCOLOGY

About Dr. Elizabeth Dole, M.D

Dr. Elizabeth Dole, M.D is a Anatomic Pathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043342769.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Dole, M.D has received a total of $779.72 in payments from pharmaceutical and medical device companies, with $54.00 received in 2023. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($725.72).

Practice Information

  • Specialty Anatomic Pathology
  • Location Dallas, TX
  • Active Since 03/09/2007
  • Last Updated 12/15/2017
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1043342769

Products in Payments

  • MEKINIST (Drug) $252.47
  • BINIMETINIB (Drug) $160.84
  • OPDIVO (Biological) $116.46
  • FUSION (Device) $54.00
  • BREATHTEK (Device) $18.78

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology Doctors in Dallas